Semler Scientific (NASDAQ:SMLR) Shares Down 5.1% – Time to Sell?

Semler Scientific, Inc. (NASDAQ:SMLR) shares traded down 5.1% during mid-day trading on Wednesday . The stock traded as low as $62.12 and last traded at $61.64. 53,241 shares changed hands during trading, a decline of 86% from the average session volume of 387,956 shares. The stock had previously closed at $64.94.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital lifted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday.

Semler Scientific Stock Performance

The stock has a market capitalization of $514.11 million, a P/E ratio of 27.05 and a beta of 1.18. The firm has a fifty day moving average price of $59.91 and a two-hundred day moving average price of $39.99.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35. The business had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. purchased a new stake in shares of Semler Scientific in the 2nd quarter worth $34,000. Quest Partners LLC lifted its position in Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after purchasing an additional 817 shares in the last quarter. US Bancorp DE grew its holdings in Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after purchasing an additional 1,158 shares during the period. Sanctuary Advisors LLC purchased a new stake in Semler Scientific in the third quarter worth about $104,000. Finally, Veery Capital LLC purchased a new stake in Semler Scientific in the fourth quarter worth about $324,000. 49.37% of the stock is currently owned by institutional investors.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.